Physician profile
William Moeller
NPI 1114942901
$752.70
in general payments reported to CMS, 2019-2025
13 companies · $42.36 in 2025
The $42.36 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $133 · 2021: $107 · 2022: $154 · 2023: $18.89 · 2024: $86.33 · 2025: $42.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $242.66 | 2019-2021 | |
| Vericel Corporation | $115.94 | 2020-2022 | |
| Depuy Synthes Sales INC. | $63.03 | 2020-2022 | |
| Bioventus LLC | $50.69 | 2024 | Gelsyn-3, Durolane |
| Medical Device Business Services, INC. | $48.00 | 2019 | |
| Horizon Therapeutics Plc | $47.77 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $46.11 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $36.73 | 2022-2025 | Zilretta, Iovera |
| Vertex Pharmaceuticals Incorporated | $27.07 | 2025 | |
| Sanara Medtech INC. | $20.17 | 2024 | Celleraterx |
| Smith+Nephew, INC. | $20.17 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $18.89 | 2023 | Seglentis |
| Baxter Healthcare | $15.47 | 2024 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Moeller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.